Fabio Petrocca, MD

I am a physician-scientist with combined training in cancer biology and clinical medicine. My research focuses on the development of immune effector cell therapies for cancer. I also maintain an active clinic for patients with benign or malignant hematologic conditions. I joined BMC in 2021 as founding Director of the Cellular Therapy Program, whose core mission is to enable equitable patient access to innovative and powerful cancer cell therapies such as CAR T.